Bio-Techne Corp
(STU:TE1)
€
69.5
0 (0%)
Market Cap: 11.07 Bil
Enterprise Value: 11.27 Bil
PE Ratio: 80.74
PB Ratio: 5.63
GF Score: 95/100 Bio-Techne Corp at Barclays Global Healthcare Conference Transcript
Mar 16, 2022 / 12:30PM GMT
Release Date Price:
€94
(+6.82%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst
All right. Good morning, everybody. I'm Luke Sergott. I cover life science tools and diagnostics here at Barclays. It's my pleasure here to introduce Chuck Kummeth, CEO of Bio-Techne. Known each other for a long time, and thank you for joining us here first in person down in Miami.
Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director
Good place to start getting out.
Questions & Answers
Luke England Sergott;Charles R. Kummeth
Barclays Bank PLC, Research Division - Research Analyst;Bio-Techne Corporation -
That's right. Right. All right. Well, so I guess we could kick it off. I've been starting everything, all these sessions with the macro. I know that there's limited exposure here from Russia and Ukraine, but are you guys -- just talk about demand trends within Europe that you're seeing. Any spillover? Any slowing of orders or anything like that across any of your end markets?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot